Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
European Urology|July 17, 2009
Words of wisdom. Re: Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Jan Adolfsson
BMJ (Clinical Research Ed.)|December 4, 2014
Authors' reply to JewellBjörn Strander, Jan Adolfsson
BMJ (Clinical Research Ed.)|November 8, 2014
Safety of modern treatment for cervical pre-cancerBjörn Strander, Jan Adolfsson
European Urology|May 1, 2007
The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidityJan Adolfsson, Bernhard Tribukait, Seymour Levitt
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methodsGunnar Steineck, Hayley Hunt, Jan Adolfsson
Lakartidningen|November 26, 2014
[Specialist referral with photography for faster diagnosis of skin tumor. Management can be better planned--and saves resources]Jan Adolfsson, Björn Cedermark, Karin Terstappen
Lakartidningen|March 5, 2013
[More randomized studies in health care can be made cheaper and more regularly]Måns Rosén, Jan Adolfsson, Jan Liliemark, et al.
The Journal of Urology|June 22, 2016
Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based StudyAndreas Thorstenson, Hans Garmo, Jan Adolfsson, et al.
BMC Urology|October 5, 2017
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsyTobias Nordström, Jan Adolfsson, Henrik Grönberg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2008
Predictors for the symptomatic prostate cancer patient's delays in seeking careLizzy Sunny, Thomas Hopfgarten, Jan Adolfsson, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
European Urology|July 17, 2009
Words of wisdom. Re: Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Jan Adolfsson
BMJ (Clinical Research Ed.)|December 4, 2014
Authors' reply to JewellBjörn Strander, Jan Adolfsson
BMJ (Clinical Research Ed.)|November 8, 2014
Safety of modern treatment for cervical pre-cancerBjörn Strander, Jan Adolfsson
European Urology|May 1, 2007
The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidityJan Adolfsson, Bernhard Tribukait, Seymour Levitt
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methodsGunnar Steineck, Hayley Hunt, Jan Adolfsson
Lakartidningen|November 26, 2014
[Specialist referral with photography for faster diagnosis of skin tumor. Management can be better planned--and saves resources]Jan Adolfsson, Björn Cedermark, Karin Terstappen
Lakartidningen|March 5, 2013
[More randomized studies in health care can be made cheaper and more regularly]Måns Rosén, Jan Adolfsson, Jan Liliemark, et al.
The Journal of Urology|June 22, 2016
Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based StudyAndreas Thorstenson, Hans Garmo, Jan Adolfsson, et al.
BMC Urology|October 5, 2017
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsyTobias Nordström, Jan Adolfsson, Henrik Grönberg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2008
Predictors for the symptomatic prostate cancer patient's delays in seeking careLizzy Sunny, Thomas Hopfgarten, Jan Adolfsson, et al.
Pageof 17